Novartis Pharmaceuticals Canada Inc.
Registration:
10
of
12
(2013-12-02
to
2015-04-30)
Legislative Proposal, Bill or Resolution
- Food and Drugs Act, specifically with respect to the approval, regulation and life-cycle management of therapeutic products and legislative modernization
- Patent Act with respect to Canada's Access to Medicines Regime (ss. 21.01-21.09)
Legislative Proposal, Bill or Resolution, Regulation
- Canada's Food and Consumer Safety Action Plan, specifically proposed legislation and regulation with respect to therapeutic products and consumer products
Policies or Program
- Canadian Agency for Drugs and Technologies in Health policies with respect to the Common Drug Review, Health Technology Assessment and the Canadian Optimal Medication Prescribing and Utilization Service
- Federal Health Partnership with respect to the coordination of federal drug plan policies and programs
- Federal public drug plans, specifically the Non-Insured Health Benefits Program (Health Canada), with respect to decisions and policies that impact reimbursement of therapeutic products for plan beneficiaries
- Industry Canada policies related to research and development of treatments for rare disorders
- International Trade Canada's Invest in Canada policies and programs with respect to investment, business development and innovation in the life sciences industry sector
- Orphan drug policy to address treatment for rare disorders
- Patented Medicines Prices Review Board with respect to excessive price guidelines
- Science and Technology Strategy led by Industry Canada, particularly with respect to the life sciences priority under the S&T Strategy
Regulation
- Food and Drug Regulations, specifically with respect to approval, regulation and life-cycle management of therapeutic products and Data Protection under section C.08.004
- Patent Act Regulations as they relate to the regulation of intellectual property for therapeutic products, specifically proposed amendments to the Patented Medicines (Notice of Compliance) Regulations.
- Patent Act Regulations with respect to Patented Medicines (Notice of Compliance) Regulations
- Patent Act as it relates to the regulation of intellectual property for therapeutic products